- Corporate
- The share
- Press releases
- Financial calendar
- Financial reports
- Financial reports – ESEF
- Prospectus and material offerings
- Financial presentations
- Corporate governance
- Analyst Coverage
- Code of Conduct
- Environmental Policy
- Code of Conduct for Suppliers
- Privacy policy
- Contact us
- Subscribe
- Thank you
- Error
Change in number of shares and votes in XVIVO Perfusion
As a result of warrants being exercised, the number of shares and votes in XVIVO Perfusion AB (publ) has during June 2017 increased by 215,000 shares and votes. As of June 30, 2017 there are thus in total 26,190,496 shares and votes in the company.
June 30, 2017
Gothenburg
Christoffer Rosenblad, CFO
XVIVO Perfusion AB (publ)
For further information please contact:
Christoffer Rosenblad, CFO, +1 720 616 2101, christoffer.rosenblad@xvivoperfusion.com
Magnus Nilsson, CEO, +46 31 788 2150, magnus.nilsson@xvivoperfusion.com
For further information on XVIVO Perfusion’s business, please refer to the company’s website, www.xvivoperfusion.com
This information is information that Xvivo Perfusion AB (publ) is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication, through the agency of the contact person set out above, at 8.30 am CET on June 30, 2017.
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.
